Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-enhanced vs. B-mode Ultrasound-guided Percutaneous Biopsy of Retroperitoneal Tumors - a Randomized Controlled Trial

NCT05659433 is registered in ClinicalTrials.gov with Iuliu Hatieganu University of Medicine and Pharmacy as lead sponsor.

NCT NCT05659433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05659433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-enhanced vs. B-mode Ultrasound-guided Percutaneous Biopsy of Retroperitoneal Tumors - a Randomized Controlled Trial
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2015
Completion date
November 30, 2022
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retroperitoneal neoplasms